Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cervical Cancer, August 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 362 articles:
HTML format


 

Single Articles

  1. KYRGIOU M, Athanasiou A, Arbyn M, Lax SF, et al
    Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP.
    Lancet Oncol. 2022;23:e385-e392.
    PubMed    
    Abstract available

  2. NOMM O, Veerus P, Orumaa M, Innos K, et al
    Effect of Pap-smear and sociodemographic factors on cervical cancer risk in Estonia: A population-based case-control study.
    Cancer Epidemiol. 2022;80:102231.
    PubMed    
    Abstract available

  3. AGGARWAL R, Sood S, Singh M, Singh K, et al
    Analysis of Rapid arc-based Radiation Therapy on Dosimetric Parameters in Cervical Cancer Patients with and without Bone Marrow Sparing.
    Asian Pac J Cancer Prev. 2022;23:2407-2413.
    PubMed    
    Abstract available

  4. NGWU CN, Iwuagwu AO, Ebimgbo SO, Igboeli EE, et al
    Perception and Practice of Cervical Cancer Screening Services and the Role of Social Workers in Facilitating Screening Uptake in Enugu State, Nigeria.
    Asian Pac J Cancer Prev. 2022;23:2271-2277.
    PubMed    
    Abstract available

  5. ASAKIJ T, Khunnarong J, Tangjitgamol S, Rongsriyam K, et al
    Salvage Treatment and Outcomes of Locally Advanced Cervical Cancer after Failed Concurrent Chemoradiation with or without Adjuvant Chemotherapy: Post Hoc Data Analysis from the ACTLACC Trial.
    Asian Pac J Cancer Prev. 2022;23:2263-2269.
    PubMed    
    Abstract available

  6. MUSTOFA, Satriyo PB, Suma AAT, Waskitha SSW, et al
    A Potent EGFR Inhibitor, N-Phenyl Pyrazoline Derivative Suppresses Aggressiveness and Cancer Stem Cell-Like Phenotype of Cervical Cancer Cells.
    Drug Des Devel Ther. 2022;16:2325-2339.
    PubMed    
    Abstract available

  7. BOITANO TKL, Ketch P, Maier JG, Nguyen CT, et al
    Increased disparities associated with black women and abnormal cervical cancer screening follow-up.
    Gynecol Oncol Rep. 2022;42:101041.
    PubMed    
    Abstract available

  8. HU Y, Zhang W, Liu Z, Xing Q, et al
    Long intergenic noncoding RNA LINC01287 drives the progression of cervical cancer via regulating miR-513a-5p/SERP1.
    Hum Cell. 2022 Jul 27. pii: 10.1007/s13577-022-00755.
    PubMed    
    Abstract available

  9. ZABIHOLLAHY F, Viswanathan AN, Schmidt EJ, Lee J, et al
    Fully automated segmentation of clinical target volume in cervical cancer from magnetic resonance imaging with convolutional neural network.
    J Appl Clin Med Phys. 2022 Jul 27:e13725. doi: 10.1002/acm2.13725.
    PubMed    
    Abstract available

  10. SILVA GAE, Alcantara LLM, Tomazelli JG, Ribeiro CM, et al
    [Evaluation of cervical cancer control actions within Brazil and its regions based on data recorded in the Brazilian Unified National Health System].
    Cad Saude Publica. 2022;38:e00041722.
    PubMed    
    Abstract available

  11. LI J, Yang N, Tian X, Ouyang L, et al
    Interference of PTK6/GAB1 signaling inhibits cell proliferation, invasion, and migration of cervical cancer cells.
    Mol Med Rep. 2022;26.
    PubMed    
    Abstract available

  12. SHEN Z, Qu A, Jiang P, Jiang Y, et al
    Re-Irradiation for Recurrent Cervical Cancer: A State-of-the-Art Review.
    Curr Oncol. 2022;29:5262-5277.
    PubMed    
    Abstract available

  13. CERINA D, Boraska Jelavic T, Buljubasic Franic M, Tomic K, et al
    Is There a Place for Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer?
    Curr Oncol. 2022;29:5223-5237.
    PubMed    
    Abstract available

  14. CASCARDI E, Cazzato G, Daniele A, Silvestris E, et al
    Association between Cervical Microbiota and HPV: Could This Be the Key to Complete Cervical Cancer Eradication?
    Biology (Basel). 2022;11.
    PubMed    
    Abstract available

  15. ALAKKAL A, Thayyullathil F, Pallichankandy S, Subburayan K, et al
    Sanguinarine Induces H2O2-Dependent Apoptosis and Ferroptosis in Human Cervical Cancer.
    Biomedicines. 2022;10.
    PubMed    
    Abstract available

  16. SNIADECKI M, Poniewierza P, Jaworek P, Szymanczyk A, et al
    Thousands of Women's Lives Depend on the Improvement of Poland's Cervical Cancer Screening and Prevention Education as Well as Better Networking Strategies Amongst Cervical Cancer Facilities.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  17. AKINYEMI OA, Abodunrin FO, Andine TF, Elleissy Nasef K, et al
    Second Malignancies Following Primary Cervical Cancer Diagnosis: Analysis of the SEER Database.
    Cureus. 2022;14:e26171.
    PubMed    
    Abstract available

  18. JIANG J, Pan Y, Li J, Xia L, et al
    Cecropin-Loaded Zeolitic Imidazolate Framework Nanoparticles with High Biocompatibility and Cervical Cancer Cell Toxicity.
    Molecules. 2022;27.
    PubMed    
    Abstract available

  19. GARDELLA B, Gritti A, Soleymaninejadian E, Pasquali MF, et al
    New Perspectives in Therapeutic Vaccines for HPV: A Critical Review.
    Medicina (Kaunas). 2022;58.
    PubMed    
    Abstract available

  20. LLUECA A, Ibanez MV, Torne A, Gil-Moreno A, et al
    Fertility-Sparing Surgery versus Radical Hysterectomy in Early Cervical Cancer: A Propensity Score Matching Analysis and Noninferiority Study.
    J Pers Med. 2022;12.
    PubMed    
    Abstract available

  21. KIM SY, Lee Y, Koh SB
    Factors Affecting the Occurrence of Mental Health Problems in Female Cancer Survivors: A Nationwide Cohort Study.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  22. HAN H, Wang X, Zhu Y, Liang Y, et al
    Organized Breast and Cervical Cancer Screening: Attendance and Determinants in Rural China.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  23. PARASHAR D, Singh A, Gupta S, Sharma A, et al
    Emerging Roles and Potential Applications of Non-Coding RNAs in Cervical Cancer.
    Genes (Basel). 2022;13.
    PubMed    
    Abstract available

  24. RAMESH J, Thilakan RC, Gopalakrishnan RM, Vijayapoopathi S, et al
    Ginsenoside Rg5 Sensitizes Paclitaxel-Resistant Human Cervical-Adeno-Carcinoma Cells to Paclitaxel-And Enhances the Anticancer Effect of Paclitaxel.
    Genes (Basel). 2022;13.
    PubMed    
    Abstract available

  25. MUHAIDAT N, Alshrouf MA, Alshajrawi RN, Miqdadi ZR, et al
    Cervical Cancer Screening among Female Refugees in Jordan: A Cross-Sectional Study.
    Healthcare (Basel). 2022;10.
    PubMed    
    Abstract available

  26. PONIEWIERZA P, Panek G
    Cervical Cancer Prophylaxis-State-of-the-Art and Perspectives.
    Healthcare (Basel). 2022;10.
    PubMed    
    Abstract available

  27. ASARE M, Abah E, Obiri-Yeboah D, Lowenstein L, et al
    HPV Self-Sampling for Cervical Cancer Screening among Women Living with HIV in Low- and Middle-Income Countries: What Do We Know and What Can Be Done?
    Healthcare (Basel). 2022;10.
    PubMed    
    Abstract available

  28. LUNA M, Upadhyay S
    Trends in the Utilization of Human Papillomavirus Vaccines and the Incidence of Malignant Cervical Cancer in Women and Teenagers: A Secondary Analysis.
    Healthcare (Basel). 2022;10.
    PubMed    
    Abstract available

  29. STUEBS FA, Koch MC, Dietl AK, Adler W, et al
    Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  30. YANG Y, Qing Y, Hao X, Fang C, et al
    APTES-Modified Remote Self-Assembled DNA-Based Electrochemical Biosensor for Human Papillomavirus DNA Detection.
    Biosensors (Basel). 2022;12.
    PubMed    
    Abstract available

  31. BONLOKKE S, Stougaard M, Sorensen BS, Booth BB, et al
    The Diagnostic Value of Circulating Cell-Free HPV DNA in Plasma from Cervical Cancer Patients.
    Cells. 2022;11.
    PubMed    
    Abstract available

  32. AWEDEW AF, Asefa Z, Belay WB
    National Burden and Trend of Cancer in Ethiopia, 2010-2019: a systemic analysis for Global burden of disease study.
    Sci Rep. 2022;12:12736.
    PubMed    
    Abstract available

  33. URBAN R, Wong J, Lim P, Zhang S, et al
    Cervical cancer patient reported gastrointestinal outcomes: intensity/volumetric modulated vs. 3D conformal radiation therapy.
    J Gynecol Oncol. 2022 Jul 7. pii: 33.e70. doi: 10.3802/jgo.2022.
    PubMed    
    Abstract available

  34. LEE WH, Kim GE, Kim YB
    Prognostic factors of dose-response relationship for nodal control in metastatic lymph nodes of cervical cancer patients undergoing definitive radiotherapy with concurrent chemotherapy.
    J Gynecol Oncol. 2022 Jun 23. pii: 33.e59. doi: 10.3802/jgo.2022.
    PubMed    
    Abstract available

  35. SCHAAFSMA M, Plante M, Mom CH, van Trommel NE, et al
    Is less more in the surgical treatment of early-stage cervical cancer?
    Curr Opin Oncol. 2022 Jul 26. pii: 00001622-990000000-00028.
    PubMed    
    Abstract available

  36. CAI S, Miao K, Tan XY, Cheng S, et al
    [Clinical research progress and implications of therapeutic vaccines for cervical cancer and precancerous lesions: a qualitative systematic review].
    Zhonghua Zhong Liu Za Zhi. 2022;44:743-760.
    PubMed    
    Abstract available


  37. [Quality control index for standardized diagnosis and treatment of cervical cancer in China (2022 edition)].
    Zhonghua Zhong Liu Za Zhi. 2022;44:615-622.
    PubMed    


  38. WANG H, Yang JL, Chen C, Zheng Y, et al
    Identification of Peptoniphilus vaginalis-Like Bacteria, Peptoniphilus septimus sp. nov., From Blood Cultures in a Cervical Cancer Patient Receiving Chemotherapy: Case and Implications.
    Front Cell Infect Microbiol. 2022;12:954355.
    PubMed    
    Abstract available

  39. ZHANG S, Wang H, Liu J, Tao T, et al
    RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation.
    J Transl Med. 2022;20:334.
    PubMed    
    Abstract available

  40. HE Z, Xie C, Qi X, Hu Z, et al
    The effect of preserving pregnancy in cervical cancer diagnosed during pregnancy: a retrospective study.
    BMC Womens Health. 2022;22:314.
    PubMed    
    Abstract available

  41. ISABIRYE A, Elwange BC, Singh K, De Allegri M, et al
    Individual and community-level determinants of cervical cancer screening in Zimbabwe: a multi-level analyses of a nationwide survey.
    BMC Womens Health. 2022;22:309.
    PubMed    
    Abstract available

  42. DELPERO E, Selk A

    CMAJ. 2022;194:E1012-E1014.
    PubMed    


  43. SAIDU R, Morhason-Bello I
    Same-day test and treat for early detection and treatment of cervical cancer in LMICs.
    Lancet Glob Health. 2022 Jul 22. pii: S2214-109X(22)00316.
    PubMed    


  44. MABUCHI S, Komura N, Kodama M, Maeda M, et al
    Significance of the Number and the Location of Metastatic Lymph Nodes in Locally Recurrent or Persistent Cervical Cancer Patients Treated with Salvage Hysterectomy plus Lymphadenectomy.
    Curr Oncol. 2022;29:4856-4867.
    PubMed    
    Abstract available

  45. CAMPOS-PARRA AD, Perez-Quintanilla M, Martinez-Gutierrez AD, Perez-Montiel D, et al
    Molecular Differences between Squamous Cell Carcinoma and Adenocarcinoma Cervical Cancer Subtypes: Potential Prognostic Biomarkers.
    Curr Oncol. 2022;29:4689-4702.
    PubMed    
    Abstract available

  46. ZHANG H, Kong W, Chen S, Zhao X, et al
    Surgical Staging of Locally Advanced Cervical Cancer: Current Status and Research Progress.
    Front Oncol. 2022;12:940807.
    PubMed    
    Abstract available

  47. LIN W, Huang W, Mei C, Zhong C, et al
    Pre-Procedural Anxiety and Associated Factors Among Women Seeking for Cervical Cancer Screening Services in Shenzhen, China: Does Past Screening Experience Matter?
    Front Oncol. 2022;12:857138.
    PubMed    
    Abstract available

  48. LI Z, Yang Q, Guo J, Liang G, et al
    Survival Outcomes of Patients With Stage IB3 Cervical Cancer Who Undergo Abdominal Radical Hysterectomy Versus Radiochemotherapy.
    Front Oncol. 2022;12:933755.
    PubMed    
    Abstract available

  49. SHU S, Li Z, Liu L, Ying X, et al
    HPV16 E6-Activated OCT4 Promotes Cervical Cancer Progression by Suppressing p53 Expression via Co-Repressor NCOR1.
    Front Oncol. 2022;12:900856.
    PubMed    
    Abstract available

  50. YOU X, Hou FY
    Clinical Efficacy of Image-Guided Radiation Therapy for Cervical Cancer and Its Impact on Patients' Serum Tumor Markers and KPS Scores.
    J Oncol. 2022;2022:8536554.
    PubMed    
    Abstract available

  51. NATIONAL HEALTH COMMISSION OF
    National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version).
    Chin J Cancer Res. 2022;34:256-269.
    PubMed    


  52. NTULI L, Mtshali A, Mzobe G, Liebenberg LJ, et al
    Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection.
    Front Cell Infect Microbiol. 2022;12:927131.
    PubMed    
    Abstract available

  53. LI Y, Dou S
    FLOT2 Promotes the Proliferation and Epithelial-mesenchymal Transition of Cervical Cancer by Activating the MEK/ERK1/2 Pathway.
    Balkan Med J. 2022;39:267-274.
    PubMed    
    Abstract available

  54. LAIOS A, Otify M, Papadopoulou A, Gallos ID, et al
    Outcomes of ovarian transposition in cervical cancer; an updated meta-analysis.
    BMC Womens Health. 2022;22:305.
    PubMed    
    Abstract available

  55. MAARSINGH JD, Laniewski P, Herbst-Kralovetz MM
    Immunometabolic and potential tumor-promoting changes in 3D cervical cell models infected with bacterial vaginosis-associated bacteria.
    Commun Biol. 2022;5:725.
    PubMed    
    Abstract available

  56. GU R, Liu M, Lin P, Feng TY, et al
    [Correlation analysis of Poor Prognosis and Immunotherapy of lncRNAs Related with m (6)A Modification in Cervical Cancer].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2022;53:626-636.
    PubMed    
    Abstract available

  57. D'CUNHA P, Gonzalez Y, Nwachukwu C, Hrycushko B, et al
    Change in image-guided planning strategies over time impacts oncologic and survival outcomes for intracavitary cervical cancer brachytherapy.
    Brachytherapy. 2022 Jul 20. pii: S1538-4721(22)00090.
    PubMed    
    Abstract available

  58. WANG W, Tian Y, Xu Y, Zhang XX, et al
    3cDe-Net: a cervical cancer cell detection network based on an improved backbone network and multiscale feature fusion.
    BMC Med Imaging. 2022;22:130.
    PubMed    
    Abstract available

  59. LIANG J, Yu F, Zhu J, Song T, et al
    [Impact of multi-leaf collimator positioning accuracy on quality control of volumetric modulation arc therapy plan for cervical cancer treated with Elekta linear accelerator].
    Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:1089-1094.
    PubMed    
    Abstract available

  60. ZHAO X, Yang K, Song Z, He H, et al
    [Juglone induces proliferation inhibition and apoptosis of cervical cancer cells via promoting c-Myc ubiquitination].
    Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:1026-1031.
    PubMed    
    Abstract available

  61. WANG J, Yu C, Jiang X, Wu X, et al
    [Vasohibin-2 promotes proliferation and metastasis of cervical cancer cells by regulating epithelial-mesenchymal transition].
    Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:966-975.
    PubMed    
    Abstract available

  62. LI H, An X, Fu Q
    MiR-218 Affects the Invasion and Metastasis of Cervical Cancer Cells by Inhibiting the Expression of SFMBT1 and DCUNIDI.
    Cell Mol Biol (Noisy-le-grand). 2022;68:81-86.
    PubMed    
    Abstract available

  63. DOMBROWSKI CA, Weston GM, Descamps PP, Izopet PJ, et al
    Health economic evaluation of an mRNA high-risk human papillomavirus (HR-HPV) assay versus a DNA HR-HPV assay for the proposed French cervical screening programme.
    Medicine (Baltimore). 2022;101:e29530.
    PubMed    
    Abstract available

  64. SOPRACORDEVOLE F, Clemente N, Papiccio M, Del Fabro A, et al
    Histopathological findings in hysterectomy for cervical stenosis in postmenopausal women: A retrospective case series.
    Medicine (Baltimore). 2022;101:e29586.
    PubMed    
    Abstract available

  65. DOUBOVA SV, Arsenault C, Contreras-Sanchez SE, Borrayo-Sanchez G, et al
    The road to recovery: an interrupted time series analysis of policy intervention to restore essential health services in Mexico during the COVID-19 pandemic.
    J Glob Health. 2022;12:05033.
    PubMed    
    Abstract available

  66. OLCZAK P, Matsui K, Wong M, Alvarez J, et al
    RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer.
    J Virol. 2022 Jun 15:e0056622. doi: 10.1128/jvi.00566.
    PubMed    
    Abstract available

  67. OKA E, Ueda Y, Nagase Y, Sawada M, et al
    Attitudes and behaviors of obstetricians and gynecologists toward HPV vaccination: a 7-year follow-up survey in Japan.
    Int J Clin Oncol. 2022;27:1356-1363.
    PubMed    
    Abstract available

  68. SILVA NNT, Santos ACS, Brito MFDS, Peixoto do Vale DBA, et al
    Levels of Folate and Vitamin B12, and Genetic Polymorphisms Involved in One-Carbon Metabolism May Increase the Risk of Cervical Cytological Abnormalities.
    Nutr Cancer. 2022;74:2779-2788.
    PubMed    
    Abstract available

  69. ALESSANDRA F, Vitalba G, Antonella B, Giulia DM, et al
    The complex relationship between infertility and female genital tract cancer: A review.
    Urologia. 2022;89:444-450.
    PubMed    
    Abstract available

  70. VAMOS CA, Kline N, Vazquez-Otero C, Lockhart EA, et al
    Stakeholders' perspectives on system-level barriers to and facilitators of HPV vaccination among Hispanic migrant farmworkers.
    Ethn Health. 2022;27:1442-1464.
    PubMed    
    Abstract available

  71. ISAAKA J, Degu A, Kimani LM
    Assessment of cisplatin-induced nephrotoxicity and its associated factors among cervical cancer patients in the leading tertiary hospital in Kenya.
    J Oncol Pharm Pract. 2022 Aug 5:10781552221119417.
    PubMed    
    Abstract available

  72. REN X, Fu Y, Liu Z, Lin X, et al
    Image-guided interstitial brachytherapy for recurrent cervical cancer after radiotherapy: A single institution experience.
    Front Oncol. 2022;12:943703.
    PubMed    
    Abstract available

  73. SHIDHAM VB
    Role of immunocytochemistry in cervical cancer screening.
    Cytojournal. 2022;19:42.
    PubMed    
    Abstract available

  74. GARG S, Shekhawat U, Vohra R, Gupta R, et al
    Pretreatment Immune Status, Predicts Response to Definite Chemo Radiotherapy in Advanced Stages of Cervical Cancer Patients.
    J Obstet Gynaecol India. 2022;72.
    PubMed    
    Abstract available

  75. ARSLAN HN, Oruc MA
    Results from a cervical cancer screening program in Samsun, Turkey.
    BMC Womens Health. 2022;22:331.
    PubMed    
    Abstract available

  76. YU M, Xue S, Chen X, Wu K, et al
    Long Non-coding RNA UCA1a Promotes Proliferation via PKM2 in Cervical Cancer.
    Reprod Sci. 2022 Aug 4. pii: 10.1007/s43032-022-01042.
    PubMed    
    Abstract available

  77. AOSHIKA T, Noda SE, Abe T, Kumazaki Y, et al
    Results of computer tomography-based adaptive brachytherapy in combination with whole-pelvic- and central-shielding-external beam radiotherapy for cervical cancer.
    Brachytherapy. 2022 Aug 1. pii: S1538-4721(22)00116.
    PubMed    
    Abstract available

  78. SUN J, Jin R
    PFKFB4 modulated by miR-195-5p can boost the malignant progression of cervical cancer cells.
    Bioorg Med Chem Lett. 2022 Aug 1:128916. doi: 10.1016/j.bmcl.2022.128916.
    PubMed    
    Abstract available

  79. CIRIS P
    Information theoretic evaluation of Lorentzian, Gaussian, Voigt, and symmetric alpha-stable models of reversible transverse relaxation in cervical cancer in vivo at 3 T.
    MAGMA. 2022 Aug 4. pii: 10.1007/s10334-022-01035.
    PubMed    
    Abstract available

  80. XU HH, Wang HL, Xing TJ, Wang XQ, et al
    A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Front Immunol. 2022;13:851622.
    PubMed    
    Abstract available

  81. LI Y, Qu J, Liu L, Sun Y, et al
    Apogossypolone Inhibits Cell Proliferation and Epithelial-Mesenchymal Transition in Cervical Cancer via Activating DKK3.
    Front Oncol. 2022;12:948023.
    PubMed    
    Abstract available

  82. ZHAO F, Ma D, Wang T, Zhang Y, et al
    The Application of Liquid-Based Cytological Detection for P16, Cytologic Evaluation and High-Risk Human Papillomavirus Testing in Cervical Cancer Screening: A Clinical Evaluation.
    Int J Womens Health. 2022;14:965-973.
    PubMed    
    Abstract available

  83. BHARDWAJ R, Boruah DK, Gogoi BB, Zahir F, et al
    Added-Value of Diffusion-Weighted Imaging (DWI) and Dynamic Contrast-Enhanced (DCE-MRI) Magnetic Resonance Imaging in the Preoperative Assessment of Cervical Cancer.
    J Obstet Gynaecol India. 2022;72:330-340.
    PubMed    
    Abstract available

  84. HUANG W, Xu H, Hu H, Zhang D, et al
    The prevalence of human papillomavirus among women in northern Guangdong Province of China.
    Sci Rep. 2022;12:13353.
    PubMed    
    Abstract available

  85. KECHAGIAS KS, Kalliala I, Bowden SJ, Athanasiou A, et al
    Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis.
    BMJ. 2022;378:e070135.
    PubMed    
    Abstract available

  86. APPIAH EO
    Cues to cervical cancer screening and reaction to cervical cancer diagnosis during screening among women in Shai Osudoku District, Ghana.
    Ecancermedicalscience. 2022;16:1392.
    PubMed    
    Abstract available

  87. DIAKITE B, Kassogue Y, Maiga M, Dolo G, et al
    Association of the Interleukin-10-592C/A Polymorphism and Cervical Cancer Risk: A Meta-Analysis.
    Genet Res (Camb). 2022;2022:2319161.
    PubMed    
    Abstract available

  88. AMMOUN R, Wami WM, Otieno P, Schultsz C, et al
    Readiness of health facilities to deliver non-communicable diseases services in Kenya: a national cross-sectional survey.
    BMC Health Serv Res. 2022;22:985.
    PubMed    
    Abstract available

  89. KEBEBEW T, Mosalo A, Mavhandu-Mudzusi AH
    Hospital-based evaluation of palliative care among patients with advanced cervical cancer: a cross-sectional study.
    BMC Palliat Care. 2022;21:140.
    PubMed    
    Abstract available

  90. SANAMI S, Rafieian-Kopaei M, Dehkordi KA, Pazoki-Toroudi H, et al
    In silico design of a multi-epitope vaccine against HPV16/18.
    BMC Bioinformatics. 2022;23:311.
    PubMed    
    Abstract available

  91. LIU Y, Kuang L, He Y, Wang X, et al
    An accidentally found metastatic cervical cancer for three years after loop electrosurgical excision procedure treatment for cervical intraepithelial neoplasia 3.
    Asian J Surg. 2022 Jul 30. pii: S1015-9584(22)00933.
    PubMed    


  92. LUCKETT KL
    Implementing a standardized protocol to improve cervical cancer screening rates in primary care.
    J Am Assoc Nurse Pract. 2022 Jul 29. pii: 01741002-990000000-00036.
    PubMed    
    Abstract available

  93. OSEI EA, Appiah S, Oti-Boadi E, Hammond D, et al
    Experiences of women awaiting cervical CANCER screening results from selected hospitals in Accra, Ghana.
    BMC Public Health. 2022;22:1467.
    PubMed    
    Abstract available

  94. LING H, Wang G, Yi B, Li Z, et al
    Clavien-Dindo classification and risk prediction model of complications after robot-assisted radical hysterectomy for cervical cancer.
    J Robot Surg. 2022 Aug 1. pii: 10.1007/s11701-022-01450.
    PubMed    
    Abstract available

  95. SHIBUYA Y, Shimada M, Tsuji K, Shigeta S, et al
    Prognostic factors of 2018 FIGO stage IB-IIA cervical cancer with absence of high/ intermediate surgical-pathological risk factors.
    Jpn J Clin Oncol. 2022 Aug 1. pii: 6652791. doi: 10.1093.
    PubMed    
    Abstract available

  96. SUN C, Wang S, Ye W, Wang R, et al
    The Prognostic Value of Tumor Size, Volume and Tumor Volume Reduction Rate During Concurrent Chemoradiotherapy in Patients With Cervical Cancer.
    Front Oncol. 2022;12:934110.
    PubMed    
    Abstract available

  97. ZHANG J, Wang K
    Mathematical Modeling and Computational Prediction of High-Risk Types of Human Papillomaviruses.
    Comput Math Methods Med. 2022;2022:1515810.
    PubMed    
    Abstract available

  98. ZHANG J, Meng S, Zhang X, Shao K, et al
    Infiltration Patterns of Cervical Epithelial Microenvironment Cells During Carcinogenesis.
    Front Immunol. 2022;13:888176.
    PubMed    
    Abstract available

  99. XU J, Ma Y, Mei H, Wang Q, et al
    Diagnostic Value of Multimodal Magnetic Resonance Imaging in Discriminating Between Metastatic and Non-Metastatic Pelvic Lymph Nodes in Cervical Cancer.
    Int J Gen Med. 2022;15:6279-6288.
    PubMed    
    Abstract available

  100. HE L, Wang Z, Chen J, Chen L, et al
    Analysis of Clinicopathological Factors Associated with Radiation-Induced Cystitis in Patients with Cervical Cancer.
    J Healthc Eng. 2022;2022:6216072.
    PubMed    
    Abstract available

  101. TEUFEL-SHONE NI, Goldtooth-Begay C, Begay AB, Lazaro A, et al
    Maintaining the Partnership Between a Tribal Breast and Cervical Cancer Program and a University-Based Cancer Prevention Center During COVID-19 Lock-Down Restrictions-A Case Study.
    Front Public Health. 2022;10:902253.
    PubMed    
    Abstract available

  102. LU J, Li Y, Wang J
    Small Cell (Neuroendocrine) Carcinoma of the Cervix: An Analysis for 19 Cases and Literature Review.
    Front Cell Infect Microbiol. 2022;12:916506.
    PubMed    
    Abstract available

  103. SU B, Zhong M, Zhang Y, Wu K, et al
    Deficiency of kin17 Facilitates Apoptosis of Cervical Cancer Cells by Modulating Caspase 3, PARP, and Bcl-2 Family Proteins.
    J Oncol. 2022;2022:3156968.
    PubMed    
    Abstract available

  104. JASPER B, Thorley E, Martins FC, Haldar K, et al
    The incidence of cervical cancer in women with postcoital bleeding and abnormal appearance of the cervix referred through the 2-week wait pathway in the United Kingdom: A retrospective cohort study.
    J Obstet Gynaecol Res. 2022 Jul 30. doi: 10.1111/jog.15366.
    PubMed    
    Abstract available

  105. LI H, Xiao Z, Xing B, Wu S, et al
    Association between common vaginal and HPV infections and results of cytology test in the Zhoupu District, Shanghai City, China, from 2014 to 2019.
    Virol J. 2022;19:127.
    PubMed    
    Abstract available

  106. URE A, Mukhedkar D, Arroyo Muhr LS
    Using HPV-meta for human papillomavirus RNA quality detection.
    Sci Rep. 2022;12:13058.
    PubMed    
    Abstract available

  107. HU C, Xu Y, Zhang Q, Liu Q, et al
    Does completion of radical hysterectomy improve oncological outcomes of women with clinical early-stage cervical cancer and intraoperative detection of nodal involvement?: protocol for a systematic review and meta-analysis.
    BMJ Open. 2022;12:e056848.
    PubMed    
    Abstract available

  108. OKYERE J, Aboagye RG, Seidu AA, Asare BY, et al
    Towards a cervical cancer-free future: women's healthcare decision making and cervical cancer screening uptake in sub-Saharan Africa.
    BMJ Open. 2022;12:e058026.
    PubMed    
    Abstract available

  109. QI L, Zhou H, Wang Y, Jablonska E, et al
    The role of selenoprotein P in the determining the sensitivity of cervical cancer patients to concurrent chemoradiotherapy: A metabonomics-based analysis.
    J Trace Elem Med Biol. 2022;73:127041.
    PubMed    
    Abstract available

  110. CASAS CPR, Albuquerque RCR, Loureiro RB, Gollner AM, et al
    Cervical cancer screening in low- and middle-income countries: A systematic review of economic evaluation studies.
    Clinics (Sao Paulo). 2022;77:100080.
    PubMed    
    Abstract available

  111. MANN S, Jess T, Allin K, Elmahdi R, et al
    Risk of Cervical Cancer in Inflammatory Bowel Disease: A Meta-Analysis of Population-Based Studies.
    Clin Transl Gastroenterol. 2022;13:e00513.
    PubMed    
    Abstract available

  112. LIU G, Hu J, Liu Y, Yuan M, et al
    Factors Influencing Lower Limb Lymphedema After Cervical Cancer Surgery: A Case-Control Study.
    Lymphat Res Biol. 2022 Jul 29. doi: 10.1089/lrb.2022.0025.
    PubMed    
    Abstract available

  113. OLTEAN T, Lippens L, Lemeire K, De Tender C, et al
    Association of Cell Death Markers With Tumor Immune Cell Infiltrates After Chemo-Radiation in Cervical Cancer.
    Front Oncol. 2022;12:892813.
    PubMed    
    Abstract available

  114. ZHENG X, Xu S, Wu J
    Cervical Cancer Imaging Features Associated With ADRB1 as a Risk Factor for Cerebral Neurovascular Metastases.
    Front Neurol. 2022;13:905761.
    PubMed    
    Abstract available

  115. PENG P, Peng X, Jiao X, Chen N, et al
    A unique Levey-Jennings control chart used for internal quality control in human papillomavirus detection.
    Virol J. 2022;19:125.
    PubMed    
    Abstract available

  116. DAVIES-OLIVEIRA JC, Round T, Crosbie EJ
    Cervical screening: the evolving landscape.
    Br J Gen Pract. 2022;72:364-365.
    PubMed    


  117. SEKINE M, Yamaguchi M, Kudo R, Hanley SJB, et al
    Problems with catch-up HPV vaccination after resumption of proactive recommendations.
    Lancet Oncol. 2022;23:972-973.
    PubMed    


  118. TASKIN MH, Nursal AF, Oruc MA, Kariptas E, et al
    Genotype Distribution and Prevalence of High-Risk Human Papillomavirus Infection among Women in Samsun Province of Turkey.
    Asian Pac J Cancer Prev. 2022;23:2477-2482.
    PubMed    
    Abstract available

  119. SUWIWAT S, Tungsinmunlong K, Siriaungkul S
    Expression of CD44v6 and RCAS1 in Uterine Cervical Carcinoma Infected with Human Papillomavirus and Its Effect on Cell Proliferation and Differentiation.
    Asian Pac J Cancer Prev. 2022;23:2431-2439.
    PubMed    
    Abstract available

  120. FIRDAUS MER, Mustopa AZ, Triratna L, Syahputra G, et al
    Dissection of Capsid Protein HPV 52 to Rationalize Vaccine Designs Using Computational Approaches Immunoinformatics and Molecular Docking.
    Asian Pac J Cancer Prev. 2022;23:2243-2253.
    PubMed    
    Abstract available

  121. GADDA IR, Khan NA, Wani SQ, Baba MH, et al
    To evaluate the use of tandem and cylinder as an intracavitary brachytherapy device for carcinoma of the cervix with regard to local control and toxicities.
    J Cancer Res Ther. 2022;18:740-746.
    PubMed    
    Abstract available

  122. VERMA ML, Singh U, Kumari R, Sachan R, et al
    Randomized controlled study for comparison of efficacy and safety between thermocoagulation and cryotherapy in visual inspection with acetic acid positive cervical lesions.
    J Cancer Res Ther. 2022;18:603-611.
    PubMed    
    Abstract available

  123. AGUSTIANSYAH P, Nurmaini S, Nuranna L, Irfannuddin I, et al
    Automated Precancerous Lesion Screening Using an Instance Segmentation Technique for Improving Accuracy.
    Sensors (Basel). 2022;22.
    PubMed    
    Abstract available

  124. SHEN-GUNTHER J, Cai H, Wang Y
    HPV Integration Site Mapping: A Rapid Method of Viral Integration Site (VIS) Analysis and Visualization Using Automated Workflows in CLC Microbial Genomics.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  125. LIU Y, Mei L, Chen Y, Zhang X, et al
    Association Between Potentially Functional Variants in chr5q14 and the Risk of Cervical Cancer in a Chinese Population.
    Reprod Sci. 2022 Jul 18. pii: 10.1007/s43032-022-01032.
    PubMed    
    Abstract available

  126. WANG S, Jiang T, Hu X, Hu H, et al
    Can the combination of DWI and T2WI radiomics improve the diagnostic efficiency of cervical squamous cell carcinoma?
    Magn Reson Imaging. 2022;92:197-202.
    PubMed    
    Abstract available

  127. PRASAD A, Khatua A, Mohanta YK, Saravanan M, et al
    Low-dose exposure to phytosynthesized gold nanoparticles combined with glutamine deprivation enhances cell death in the cancer cell line HeLa via oxidative stress-mediated mitochondrial dysfunction and G0/G1 cell cycle arrest.
    Nanoscale. 2022;14:10399-10417.
    PubMed    
    Abstract available

  128. GULER OC, Onal C
    Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo)radiotherapy: a systematic review and metaanalysis. In regard to De Virgilio et al.
    J Cancer Res Clin Oncol. 2022;148:2567-2568.
    PubMed    
    Abstract available

  129. LANDY R, Hollingworth T, Waller J, Marlow LA, et al
    Non-speculum clinician-taken samples for human papillomavirus testing: a cross-sectional study in older women.
    Br J Gen Pract. 2022;72:e538-e545.
    PubMed    
    Abstract available

  130. BUKOWSKI A, Hoyo C, Hudgens MG, Brewster WR, et al
    Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1564-1571.
    PubMed    
    Abstract available

  131. GOYAL A, Heymann JJ, Alperstein SA, Siddiqui MT, et al
    Underrecognized Patterns of High-Grade Squamous Intraepithelial Lesion on ThinPrep Preparations.
    Am J Clin Pathol. 2022;158:315.
    PubMed    


  132. AKSAKAL SE, Pay RE, Kose C, Altinbas SK, et al
    The effect of anterior uterocervical angle and cervical length on the development of pelvic inflammatory disease.
    Clin Anat. 2022;35:732-737.
    PubMed    
    Abstract available

  133. KATO T, Ono T, Narita Y, Komori S, et al
    Dose-volume comparison of intensity modulated proton therapy and volumetric modulated arc therapy for cervical esophageal cancer.
    Med Dosim. 2022;47:216-221.
    PubMed    
    Abstract available

  134. CANPOLAT M, Birge O, Danisman T, Uncu YA, et al
    The detection of cervical neoplasia via optical imaging: a pilot clinical study.
    Arch Gynecol Obstet. 2022;306:433-441.
    PubMed    
    Abstract available

  135. MOHAMMED KE, Nagar T, Pearson SM, Donaldson J, et al
    Dosimetric comparison of high-dose rate cervix brachytherapy with and without interstitial needles and the impact on target volume coverage, and organ at risk constraints.
    J Med Imaging Radiat Oncol. 2022;66:671-677.
    PubMed    
    Abstract available

  136. DELLA CORTE L, Mercorio A, Giampaolino P, Vitale SG, et al
    The role of endocervicoscopy in women with cervical intraepithelial neoplasia: a systematic review of the literature.
    Updates Surg. 2022;74:1239-1245.
    PubMed    
    Abstract available

  137. KAMPERS J, Gerhardt E, Sibbertsen P, Flock T, et al
    Perioperative morbidity of different operative approaches in early cervical carcinoma: a systematic review and meta-analysis comparing minimally invasive versus open radical hysterectomy.
    Arch Gynecol Obstet. 2022;306:295-314.
    PubMed    
    Abstract available

  138. YU N, Basnayake C, Connell W, Ding NS, et al
    Interventions to Improve Adherence to Preventive Care in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2021 Oct 7. pii: 6383125. doi: 10.1093.
    PubMed    
    Abstract available

  139. YE L, Jiang J, Fang Y, Cao C, et al
    Study on the clinical significance of cervical conization under the guidance of colposcopy in the treatment of cervical lesions.
    Minerva Med. 2022;113:745-748.
    PubMed    


  140. HO FDV, Arevalo MVPN, de Claro PTS, Jacomina LE, et al
    Breast and cervical cancer screening in the Philippines: Challenges and steps forward.
    Prev Med Rep. 2022;29:101936.
    PubMed    
    Abstract available

  141. CATARINO R, Vassilakos P, Petignat P, Combescure C, et al
    Harms and benefits of cervical cancer screening among non-attenders in Switzerland: The transition towards HPV-based screening.
    Prev Med Rep. 2022;29:101929.
    PubMed    
    Abstract available


  142. Long Intergenic Non-Coding RNA LINC00885 Promotes Tumorigenesis of Cervical Cancer by Upregulating MACC1 Expression Through Serving as a Competitive Endogenous RNA for microRNA-432-5p [Expression of Concern].
    Cancer Manag Res. 2022;14:2307-2308.
    PubMed    


  143. LU H, Li L, Cheng Y, Yang Z, et al
    Timely Estimates of 5-Year Relative Survival for Patients With Cervical Cancer: A Period Analysis Using Cancer Registry Data From Taizhou, Eastern China.
    Front Public Health. 2022;10:926058.
    PubMed    
    Abstract available

  144. CHUA BWB, Neo P, Ma VY, Lim LM, et al
    Health care provider's experience and perspective of cervical cancer screening in Singapore: A qualitative study.
    Front Public Health. 2022;10:853453.
    PubMed    
    Abstract available

  145. TEIXEIRA JC, Vale DB
    A promising technique to improve and expand the practice of colposcopy to help the global fight against cervical cancer.
    Ann Transl Med. 2022;10:723.
    PubMed    


  146. MUNOZ-BELLO JO, Carrillo-Garcia A, Lizano M
    Epidemiology and Molecular Biology of HPV Variants in Cervical Cancer: The State of the Art in Mexico.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  147. TRYBUS W, Trybus E, Krol T
    Emodin Sensitizes Cervical Cancer Cells to Vinblastine by Inducing Apoptosis and Mitotic Death.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  148. MORAND GB, Cardona I, Cruz SBSC, Mlynarek AM, et al
    Therapeutic Vaccines for HPV-Associated Oropharyngeal and Cervical Cancer: The Next De-Intensification Strategy?
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  149. ANDIWIJAYA FR, Davey C, Bessame K, Ndong A, et al
    Disability and Participation in Breast and Cervical Cancer Screening: A Systematic Review and Meta-Analysis.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  150. ZIBAKO P, Hlongwa M, Tsikai N, Manyame S, et al
    Mapping Evidence on Management of Cervical Cancer in Sub-Saharan Africa: Scoping Review.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  151. BATMAN SH, Schmeler KM
    Fertility-Sparing and Less Radical Surgery for Cervical Cancer.
    Curr Oncol Rep. 2022 Aug 12. pii: 10.1007/s11912-022-01317.
    PubMed    
    Abstract available

  152. WANG J, Chen Y, Xie H, Luo L, et al
    Evaluation of auto-segmentation for EBRT planning structures using deep learning-based workflow on cervical cancer.
    Sci Rep. 2022;12:13650.
    PubMed    
    Abstract available

  153. LEE TH, Kim KS, Kim HJ, Choi CH, et al
    Image-Guided Versus Conventional Brachytherapy for Locally Advanced Cervical Cancer: Experience of Single Institution with the Same Practitioner and Time Period.
    Cancer Res Treat. 2022 Aug 10. pii: crt.2022.418. doi: 10.4143/crt.2022.
    PubMed    
    Abstract available

  154. IBARRA-BERUMEN J, Moreno-Eutimio MA, Rosales-Castro M, Ordaz-Pichardo C, et al
    Cytotoxic effect and induction of apoptosis in human cervical cancer cells by a wood extract from Prosopis laevigata.
    Drug Chem Toxicol. 2022 Aug 11:1-13. doi: 10.1080/01480545.2022.2109046.
    PubMed    
    Abstract available

  155. MEIXNER E, Hoeltgen L, Hoegen P, Konig L, et al
    Age-Dependent Hematologic Toxicity Profiles and Prognostic Serologic Markers in Postoperative Radiochemotherapy Treatment for Uterine Cervical Cancer.
    Technol Cancer Res Treat. 2022;21:15330338221118188.
    PubMed    
    Abstract available

  156. XU Z, Huang L, Zhang T, Liu Y, et al
    Shikonin inhibits the proliferation of cervical cancer cells via FAK/AKT/GSK3beta signalling.
    Oncol Lett. 2022;24:304.
    PubMed    
    Abstract available

  157. ASANGBEH-KERMAN SL, Davidovic M, Taghavi K, Kachingwe J, et al
    Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies.
    BMC Public Health. 2022;22:1530.
    PubMed    
    Abstract available

  158. MILLER EA, Pinsky PF
    Cervical cancer screening and predictors of screening by diabetes status.
    Cancer Causes Control. 2022 Aug 10. pii: 10.1007/s10552-022-01615.
    PubMed    
    Abstract available

  159. CHAN DNS, Law BMH, So WKW, Fan N, et al
    Factors associated with cervical cancer screening utilisation by people with physical disabilities: A systematic review.
    Health Policy. 2022 Aug 3. pii: S0168-8510(22)00219.
    PubMed    
    Abstract available

  160. LI X, Rao X, Wei MJ, Lu WG, et al
    Extended HPV Genotyping for Risk Assessment of Cervical Intraepithelial Neoplasia Grade 2/3 or Worse in a Cohort Study.
    J Natl Compr Canc Netw. 2022;20:906-914.
    PubMed    
    Abstract available

  161. EPHREM DIBISA K, Tamiru Dinka M, Mekonen Moti L, Fetensa G, et al
    Precancerous Lesion of the Cervix and Associated Factors Among Women of West Wollega, West Ethiopia, 2022.
    Cancer Control. 2022;29:10732748221117900.
    PubMed    
    Abstract available

  162. MARCHOCKI Z, Swift B, Covens A
    Small Cell and Other Rare Histologic Types of Cervical Cancer.
    Curr Oncol Rep. 2022 Aug 10. pii: 10.1007/s11912-022-01316.
    PubMed    
    Abstract available

  163. QIAN M, Wang L, Xing J, Shan X, et al
    Prevalence of sexual dysfunction in women with cervical cancer: a systematic review and meta-analysis.
    Psychol Health Med. 2022 Aug 10:1-15. doi: 10.1080/13548506.2022.2110270.
    PubMed    
    Abstract available

  164. JIANG Y, Xu W, Tao J
    Circular RNA circVPRBP serves as a microRNA-106b-5p sponge to regulate proliferation and metastasis of cervical cancer cells via tripartite motif-containing protein 3.
    Anticancer Drugs. 2022 Aug 10. pii: 00001813-990000000-00037.
    PubMed    
    Abstract available

  165. SHIM SJ, Kim NY, Lee HJ, Gong SJ, et al
    Successful treatment of a patient with recurrent metastatic clear cell carcinoma of the uterine cervix.
    Indian J Cancer. 2022;59:269-272.
    PubMed    
    Abstract available

  166. SEFUTHI T, Nkonki L
    A systematic review of economic evaluations of cervical cancer screening methods.
    Syst Rev. 2022;11:162.
    PubMed    
    Abstract available

  167. WARDEN CD, Cholli P, Qin H, Guo C, et al
    HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study.
    Infect Agent Cancer. 2022;17:44.
    PubMed    
    Abstract available

  168. VIDAL-GUTIERREZ M, Torres-Moreno H, Arenas-Luna V, Loredo-Mendoza ML, et al
    Standardized phytopreparations and cucurbitacin IIb from Ibervillea sonorae (S. Watson) greene induce apoptosis in cervical cancer cells by Nrf2 inhibition.
    J Ethnopharmacol. 2022 Aug 6:115606. doi: 10.1016/j.jep.2022.115606.
    PubMed    
    Abstract available

  169. HERMESSE J, Pleyers C, Gennigens C, De Cuypere M, et al
    Outcome analysis of HDR compared to PDR IGABT in locally advanced cervical cancer: a single-center cohort analysis.
    Strahlenther Onkol. 2022 Aug 9. pii: 10.1007/s00066-022-01982.
    PubMed    
    Abstract available

  170. FAKHROLMOBASHERI M, Mousavi Seresht L
    Cost-Effectiveness of HPV vaccination; Need for Economic and Social Policy Intervention.
    Arch Iran Med. 2022;25:343-346.
    PubMed    


  171. LANG X, Huang C, Cui H
    Prognosis Analysis and Validation of Fatty Acid Metabolism-Related lncRNAs and Tumor Immune Microenvironment in Cervical Cancer.
    J Immunol Res. 2022;2022:4954457.
    PubMed    
    Abstract available

  172. GIZAW AT, El-Khatib Z, Wolancho W, Amdissa D, et al
    Uptake of cervical cancer screening and its predictors among women of reproductive age in Gomma district, South West Ethiopia: a community-based cross-sectional study.
    Infect Agent Cancer. 2022;17:43.
    PubMed    
    Abstract available

  173. KIM J, Dove MS, Dang JHT
    Sociodemographic factors associated with HPV awareness/knowledge and cervical cancer screening behaviors among caregivers in the U.S.
    BMC Womens Health. 2022;22:335.
    PubMed    
    Abstract available

  174. BRUM VOR, Tricoti ASO, Pannain GD, Drumond DG, et al
    Cytology-based Screening for Anal Intraepithelial Neoplasia in Immunocompetent Brazilian Women with a History of High-Grade Cervical Intraepithelial Neoplasia or Cancer.
    Rev Bras Ginecol Obstet. 2022;44:678-685.
    PubMed    
    Abstract available

  175. TEKA B, Gizaw M, Firdawoke E, Addissie A, et al
    A Technical Comparison of Human Papillomavirus Genotyping Assays from a Population-Based Cervical Cancer Screening in South Central Ethiopia.
    Cancer Manag Res. 2022;14:2253-2263.
    PubMed    
    Abstract available

  176. FANG F, Guo C, Zheng W, Li Q, et al
    LINC00707 Promotes Cell Proliferation in Cervical Cancer via the miR-374c-5p/SDC4 Axis.
    Biomed Res Int. 2022;2022:5793912.
    PubMed    
    Abstract available

  177. MENG S, Liu Y, Wang X, Wu X, et al
    The prognostic value and biological significance of gap junction beta protein 2 (GJB2 or Cx26) in cervical cancer.
    Front Oncol. 2022;12:907960.
    PubMed    
    Abstract available

  178. CHEN F, Chen L, Zhang Y, Shi L, et al
    Survival Comparison Between Squamous Cell Carcinoma and Adenocarcinoma for Radiotherapy-Treated Patients with Stage IIB-IVA Cervical Cancer.
    Front Oncol. 2022;12:895122.
    PubMed    
    Abstract available

  179. WU Y, Chen T, Huang Y, Li Y, et al
    MRI Using Artificial Intelligence Algorithm to Evaluate Concurrent Chemoradiotherapy for Local Recurrence and Distant Metastasis of Cervical Squamous Cell Carcinoma.
    Comput Math Methods Med. 2022;2022:4449696.
    PubMed    
    Abstract available

  180. QIN L, Luo X, Qin X, Huang H, et al
    Comprehensive Expression Profiling and Molecular Basis of CDC28 Protein Kinase Regulatory Subunit 2 in Cervical Cancer.
    Int J Genomics. 2022;2022:6084549.
    PubMed    
    Abstract available

  181. QIN W, He C, Jiang D, Gao Y, et al
    Systematic Construction and Validation of a Novel Ferroptosis-Related Gene Model for Predicting Prognosis in Cervical Cancer.
    J Immunol Res. 2022;2022:2148215.
    PubMed    
    Abstract available

  182. TERADA S, Terai Y, Tanaka Y, Tanaka T, et al
    Postsurgical urodynamic study of total laparoscopic nerve-sparing radical hysterectomy for uterine cervical cancer.
    J Obstet Gynaecol Res. 2022 Aug 7. doi: 10.1111/jog.15371.
    PubMed    
    Abstract available

  183. LIU X, Yang R, Xu Q, Zhou M, et al
    Tautomeric phytosterols from Vernonia amygdalina Delile and their anti-cervical cancer activity.
    Bioorg Chem. 2022;128:106068.
    PubMed    
    Abstract available

  184. MONROY-MORA A, de Lourdes Mora-Garcia M, Alheli Monroy Mora K, Hernandez-Montes J, et al
    Inhibition of adenosine deaminase activity reverses resistance to the cytotoxic effect of high adenosine levels in cervical cancer cells.
    Cytokine. 2022;158:155977.
    PubMed    
    Abstract available

  185. JAQUA E, Nguyen V, Morton K, Chin E, et al
    Improving Cervical Cancer Screening Rates at an Urban Federally Qualified Health Center Family Medicine Residency Clinic.
    Perm J. 2022;26:21-27.
    PubMed    
    Abstract available

  186. ABDALVAND N, Sadeghi M, Mahdavi SR, Abdollahi H, et al
    Brachytherapy outcome modeling in cervical cancer patients: A predictive machine learning study on patient-specific clinical, physical and dosimetric parameters.
    Brachytherapy. 2022 Aug 3. pii: S1538-4721(22)00113.
    PubMed    
    Abstract available

  187. BEN DHIA S, Berthou H, Warcoin M, Rodrigues M, et al
    Combined-modality treatment for locally advanced cervical cancer in a woman with Bloom-like syndrome: A case report and review of the literature.
    Strahlenther Onkol. 2022 Aug 5. pii: 10.1007/s00066-022-01981.
    PubMed    
    Abstract available

  188. CHEN Y, Chen J, Lin X, Zheng J, et al
    A Prognostic Nomogram for Predicting Overall Survival in Patients With Small-Cell Carcinoma of the Uterine Cervix: A SEER Population-Based Study.
    Technol Cancer Res Treat. 2022;21:15330338221110673.
    PubMed    
    Abstract available

  189. KIM J, Heo DH, Lee DC, Park CK, et al
    Surgical Removal of Cervical Extradural Cysts Using the Biportal Endoscopic Approach.
    World Neurosurg. 2022;164:228-236.
    PubMed    
    Abstract available

  190. BAHAMONDES L, Maria Y Makuch
    Awareness of the non-contraceptive benefits of reversible contraceptive methods in a cohort of Brazilian women: an exploratory study.
    Eur J Contracept Reprod Health Care. 2022;27:294-299.
    PubMed    
    Abstract available

  191. MA S, Olchanski N, Cohen JT, Ollendorf DA, et al
    The Impact of Broader Value Elements on Cost-Effectiveness Analysis: Two Case Studies.
    Value Health. 2022;25:1336-1343.
    PubMed    
    Abstract available

  192. HORN LC, Beckmann MW, Follmann M, Koch MC, et al
    [Revised German guidelines on the diagnosis and treatment of carcinoma of the uterine cervix-what's new for pathologists in 2021?]
    Pathologie (Heidelb). 2022;43:292-302.
    PubMed    
    Abstract available

  193. AKCAY M, Etiz D, Celik O, Ozen A, et al
    Evaluation of acute hematological toxicity by machine learning in gynecologic cancers using postoperative radiotherapy.
    Indian J Cancer. 2022;59:178-186.
    PubMed    
    Abstract available

  194. WAN X, Hu T, Wu H, Cheng X, et al
    Predictive values of PDL1 expression for survival outcomes in patients with cervical cancer: a systematic review and meta-analysis.
    Ginekol Pol. 2022 Aug 19. pii: VM/OJS/J/89728. doi: 10.5603/GP.a2022.0071.
    PubMed    
    Abstract available

  195. KHUMALO PG, Carey M, Mackenzie L, Sanson-Fisher R, et al
    Cervical cancer screening-related knowledge among community health workers in Eswatini: a cross-sectional survey.
    Health Promot Int. 2022;37.
    PubMed    
    Abstract available

  196. ZHANG Z, Hu Q, Ye S, Xiang L, et al
    Inhibition of the PIN1-NRF2/GPX4 axis imparts sensitivity to cisplatin in cervical cancer cells.
    Acta Biochim Biophys Sin (Shanghai). 2022 Aug 25. doi: 10.3724/abbs.2022109.
    PubMed    
    Abstract available

  197. ZHOU G, Zhou F, Gu Y, Zhang M, et al
    Vaginal Microbial Environment Skews Macrophage Polarization and Contributes to Cervical Cancer Development.
    J Immunol Res. 2022;2022:3525735.
    PubMed    
    Abstract available

  198. LU Y, Xu L, Lin X, Qi X, et al
    Analysis of the Effect of Fast Recovery Surgery Concept on Perioperative Nursing Care of Patients with Radical Resection of Cervical Cancer and Its Influence on Psychological Status.
    Evid Based Complement Alternat Med. 2022;2022:2023159.
    PubMed    
    Abstract available

  199. LI Y, Wu W, Sun Y, Yu D, et al
    The clinical evaluation of atlas-based auto-segmentation for automatic contouring during cervical cancer radiotherapy.
    Front Oncol. 2022;12:945053.
    PubMed    
    Abstract available

  200. DEMA E, Sonnenberg P, Gibbs J, Conolly A, et al
    How did the COVID-19 pandemic affect access to condoms, chlamydia and HIV testing, and cervical cancer screening at a population level in Britain? (Natsal-COVID).
    Sex Transm Infect. 2022 Aug 18. pii: sextrans-2022-055516.
    PubMed    
    Abstract available

  201. LIU Y, Liu H, Sheng B, Pan S, et al
    The functions of lncRNAs in the HPV-negative cervical cancer compared with HPV-positive cervical cancer.
    Apoptosis. 2022 Aug 18. pii: 10.1007/s10495-022-01761.
    PubMed    
    Abstract available

  202. POPALIS ML, Ramirez SI, Leach KM, Granzow ME, et al
    Improving cervical cancer screening rates: a scoping review of resources and interventions.
    Cancer Causes Control. 2022 Aug 18. pii: 10.1007/s10552-022-01618.
    PubMed    
    Abstract available

  203. GUAN C, Wang B, Dong Q
    The IncRNA SCIRT Promotes the Proliferative, Migratory, and Invasive Properties of Cervical Cancer Cells by Upregulating MMP-2/-9.
    J Oncol. 2022;2022:3448224.
    PubMed    
    Abstract available

  204. YANG B, Cai Y, Zhu P, Jiang Z, et al
    Transmembrane protein 121 as a novel inhibitor of cervical cancer metastasis.
    Exp Ther Med. 2022;24:572.
    PubMed    
    Abstract available

  205. LIU J, Tang G, Zhou Q, Kuang W, et al
    Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Radiat Oncol. 2022;17:142.
    PubMed    
    Abstract available

  206. ELMORE CE, Mitchell EM, Debnam K, Keim-Malpass J, et al
    Predictors of cervical cancer screening for refugee women attending an international family medicine clinic in the United States.
    Cancer Causes Control. 2022 Aug 17. pii: 10.1007/s10552-022-01612.
    PubMed    
    Abstract available

  207. LI J, Liu G, Luo J, Yan S, et al
    Cervical cancer prognosis and related risk factors for patients with cervical cancer: a long-term retrospective cohort study.
    Sci Rep. 2022;12:13994.
    PubMed    
    Abstract available

  208. LIU P, Pei JJ, Li L, Li JW, et al
    Sildenafil inhibits the growth and epithelial-to-mesenchymal transition of cervical cancer via the TGF-beta1/Smad2/3 pathway.
    Curr Cancer Drug Targets. 2022 Aug 16. pii: CCDT-EPUB-125488.
    PubMed    
    Abstract available

  209. SHINAN-ALTMAN S, Levkovich I, Hamama-Raz Y
    Cervical cancer survivors: The experiences of the journey.
    Palliat Support Care. 2022 Aug 17:1-8. doi: 10.1017/S1478951522000785.
    PubMed    
    Abstract available

  210. HOSSEINI E, Yaghoubian SS, Hashemi-Soteh SMB
    The Frequency and Typing of HPV Virus Among Suspected Women Referred to HPV Genotyping Test in Mazandaran, Northern Iran.
    Clin Lab. 2022;68.
    PubMed    
    Abstract available

  211. HAJIESMAEIL M, Mirzaei Dahka S, Khorrami R, Rastgoo S, et al
    Intake of food groups and cervical cancer in women at risk for cervical cancer: A nested case-control study.
    Caspian J Intern Med. 2022;13:599-606.
    PubMed    
    Abstract available

  212. YI J, Lei X, Zhang L, Zheng Q, et al
    The Influence of Different Ultrasonic Machines on Radiomics Models in Prediction Lymph Node Metastasis for Patients with Cervical Cancer.
    Technol Cancer Res Treat. 2022;21:15330338221118412.
    PubMed    
    Abstract available

  213. CHUNG SH, Oshima K, Singleton M, Thomason J, et al
    Determinants of Cervical Cancer Screening Patterns Among Women with Systemic Lupus Erythematosus.
    J Rheumatol. 2022 Aug 15. pii: jrheum.220105. doi: 10.3899/jrheum.220105.
    PubMed    
    Abstract available

  214. BAI Z, Shi J, Wang J, Zhong J, et al
    ADC and kinetic parameter of primary tumor: Surrogate imaging markers for fertility-sparing vaginal radical trachelectomy in patients with stage IB cervical cancer.
    Eur J Radiol. 2022;155:110467.
    PubMed    
    Abstract available

  215. ZHU P, Tatar O, Haward B, Griffin-Mathieu G, et al
    Assessing Canadian women's preferences for cervical cancer screening: A brief report.
    Front Public Health. 2022;10:962039.
    PubMed    
    Abstract available

  216. HAN GH, Yun H, Kim J, Chung JY, et al
    Overexpression of glucocorticoid receptor promotes the poor progression and induces cisplatin resistance through p38 MAP kinase in cervical cancer patients.
    Am J Cancer Res. 2022;12:3437-3454.
    PubMed    
    Abstract available

  217. CUI H, Zhang B, Ruan M, Fang C, et al
    Overexpression of miR-3653 is Associated with HPV Infection and Serves as a Biomarker in Patients with Cervical Cancer.
    Int J Womens Health. 2022;14:1037-1045.
    PubMed    
    Abstract available

  218. LI T, Lai Y, Yuan J
    The diagnostic accuracy of TCT + HPV-DNA for cervical cancer: systematic review and meta-analysis.
    Ann Transl Med. 2022;10:761.
    PubMed    
    Abstract available

  219. ZHANG Z, Xiang K, Tan L, Du X, et al
    Identification of critical genes associated with radiotherapy resistance in cervical cancer by bioinformatics.
    Front Oncol. 2022;12:967386.
    PubMed    
    Abstract available

  220. ZHANG J, Shen Q, Xia L, Zhu X, et al
    DYNLT3 overexpression induces apoptosis and inhibits cell growth and migration via inhibition of the Wnt pathway and EMT in cervical cancer.
    Front Oncol. 2022;12:889238.
    PubMed    
    Abstract available

  221. HERNANDEZ-AGUADO JJ, de La Fuente-Valero J, Ramirez Mena M, Ortega-Medina L, et al
    Comparative pilot study about HPV test with partial genotyping in primary screening versus other strategies for cervical cancer population screening, CRYGEN 16/18 study.
    Enferm Infecc Microbiol Clin (Engl Ed). 2022 Aug 10. pii: S2529-993X(22)00169.
    PubMed    
    Abstract available

  222. HEITZ N, Greer SC, Halford Z
    A Review of Tisotumab Vedotin-tftv in Recurrent or Metastatic Cervical Cancer.
    Ann Pharmacother. 2022 Aug 12:10600280221118370. doi: 10.1177/10600280221118370.
    PubMed    
    Abstract available

  223. KIARIE H, Temmerman M, Nyamai M, Liku N, et al
    The COVID-19 pandemic and disruptions to essential health services in Kenya: a retrospective time-series analysis.
    Lancet Glob Health. 2022;10:e1257-e1267.
    PubMed    
    Abstract available

  224. PARASCANDOLA M, Neta G, Salloum RG, Shelley D, et al
    Role of Local Evidence in Transferring Evidence-Based Interventions to Low- and Middle-Income Country Settings: Application to Global Cancer Prevention and Control.
    JCO Glob Oncol. 2022;8:e2200054.
    PubMed    
    Abstract available

  225. GARGIN V, Volokhova H, Koshelnyk O, Gulbs O, et al
    THE INFLUENCE OF IMMUNODEFICIENCY ON THE LEVEL OF CD34-POSITIVE CELLS IN THE CERVIX.
    Georgian Med News. 2022;:40-44.
    PubMed    
    Abstract available

  226. WENCEL-WAWRZENCZYK A, Lewitowicz P, Lewandowska A, Saluga A, et al
    Sexual Behavior and the Awareness Level of Common Risk Factors for the Development of Cervical, Anogenital and Oropharyngeal Cancer among Women Subjected to HR HPV DNA-Testing.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  227. ARMIN JS, Williamson HJ, Begay A, Etcitty J, et al
    Adapting a Cancer Screening Education Program for Native American Women with Disabilities.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  228. VALLELY AJB, Saville M, Badman SG, Gabuzzi J, et al
    Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).
    Lancet Glob Health. 2022;10:e1336-e1346.
    PubMed    
    Abstract available

  229. SHIRAZ A, Egawa N, Pelt DM, Crawford R, et al
    Cervical cell lift: A novel triage method for the spatial mapping and grading of precancerous cervical lesions.
    EBioMedicine. 2022;82:104157.
    PubMed    
    Abstract available

  230. IMANISHI Y, Kinoshita T, Sakamoto M, Ichimiya M, et al
    Importance of human papillomavirus vaccination leaflets focusing on the safety profile targeted pediatricians in Japan.
    Vaccine. 2022 Jul 13. pii: S0264-410X(22)00861.
    PubMed    
    Abstract available

  231. CASTILLO-CANO B, Martin-Perez M, Llorente-Garcia A, Montero-Corominas D, et al
    Assessment of thyroiditis risk associated with HPV vaccination among girls aged 9-18 years: A time-varying cohort study.
    Vaccine. 2022 Jul 2. pii: S0264-410X(22)00829.
    PubMed    
    Abstract available

  232. MLINARIC M, Krizmaric M, Takac I, Repse Fokter A, et al
    Identification of women with high grade histopathology results after conisation by artificial neural networks.
    Radiol Oncol. 2022;56:355-364.
    PubMed    
    Abstract available

  233. MCCLYMONT E, Albert AY, Wang C, Dos Santos SJ, et al
    Vaginal microbiota associated with oncogenic HPV in a cohort of HPV-vaccinated women living with HIV.
    Int J STD AIDS. 2022 Jul 1:9564624221109686. doi: 10.1177/09564624221109686.
    PubMed    
    Abstract available

  234. QU N, Wang R, Meng Y, Liu N, et al
    Methionine enkephalin inhibited cervical carcinoma via apoptosis promotion and reduction of myeloid derived suppressor cell infiltrated in tumor.
    Int Immunopharmacol. 2022;110:108933.
    PubMed    
    Abstract available

  235. VILASBOAS-RIBEIRO I, Nouwens SAN, Curto S, Jager B, et al
    POD-Kalman filtering for improving noninvasive 3D temperature monitoring in MR-guided hyperthermia.
    Med Phys. 2022;49:4955-4970.
    PubMed    
    Abstract available

  236. ALTAY-KOCAK A, Kazanci F, Dogu-Tok C, Onan A, et al
    The prevalence and distribution of human papillomavirus in 4267 Turkish women with or without cervical lesions: A hospital-based study.
    J Med Virol. 2022;94:5026-5032.
    PubMed    
    Abstract available

  237. MEHTA A, Markman B, Rodriguez-Cintron W
    Don't jump down my throat: gender gap in HPV vaccinations risk long term cancer threats.
    Expert Rev Vaccines. 2022;21:1045-1053.
    PubMed    
    Abstract available

  238. STOLNICU S, Hoang L, Almadani N, De Brot L, et al
    Clinical correlation of lymphovascular invasion and Silva pattern of invasion in early-stage endocervical adenocarcinoma: proposed binary Silva classification system.
    Pathology. 2022;54:548-554.
    PubMed    
    Abstract available

  239. DRYSDALE H, Marlow LA, Lim A, Sasieni P, et al
    Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England.
    J Med Screen. 2022;29:194-202.
    PubMed    
    Abstract available

  240. SHI H, Shao Y, Zhang H, Ye L, et al
    Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020).
    Pathology. 2022;54:555-562.
    PubMed    
    Abstract available

  241. SULTANA F, Gertig DM, English DR, Simpson JA, et al
    HPV self-sampling and follow-up over two rounds of cervical screening in Australia - the iPap trial.
    J Med Screen. 2022;29:185-193.
    PubMed    
    Abstract available

  242. SAYYAH-MELLI M, Shokohi B, Yagoobi S, Adili A, et al
    Immature teratoma of the uterine cervix.
    J Obstet Gynaecol. 2022;42:1600-1601.
    PubMed    


  243. SAH S, Borkar PV, Wight C, Kelly P, et al
    Low-grade Neuroendocrine Tumor of the Cervix: Report of 3 Cases of a Rare Neoplasm With Review of the Literature.
    Int J Gynecol Pathol. 2022;41:437-446.
    PubMed    
    Abstract available

  244. GOLD RS, Amir H, Baruch Y, Gordon D, et al
    The Manchester operation - is it time for it to return to our surgical armamentarium in the twenty-first century?
    J Obstet Gynaecol. 2022;42:1419-1423.
    PubMed    
    Abstract available

  245. BULUTAY P, Haberal N, Ozen O, Erdem O, et al
    Reproducibility of Morphologic Parameters of the International Endocervical Adenocarcinoma Criteria and Classification System and Correlation With Clinicopathologic Parameters: A Multi-Institutional Study.
    Int J Gynecol Pathol. 2022;41:447-458.
    PubMed    
    Abstract available

  246. MOOSSAVI M, Shojaee M, Mousavi M, Alaei M, et al
    Evaluating the HLA-G (rs1063320) genetic variant and risk of human papillomavirus infection: a meta-analysis of 953 cases and 877 controls.
    J Obstet Gynaecol. 2022;42:1352-1357.
    PubMed    
    Abstract available

  247. KATAFUCHI T, Kawakami F, Iwagoi Y, Saito F, et al
    "Neuroendocrine Tumor Grade 3 (NET G3)" of the Uterine Cervix: A Report of 2 Cases.
    Int J Gynecol Pathol. 2022;41:470-475.
    PubMed    
    Abstract available

  248. ZHANG W, Gao Y, Zhang W, Lin Z, et al
    Survival outcomes and prognostic factors of papillary serous adenocarcinoma and papillary squamous cell carcinoma of the uterine cervix.
    J Obstet Gynaecol. 2022;42:1233-1238.
    PubMed    
    Abstract available

  249. WANG J, Chen X, Zheng L, Ding C, et al
    Circ_0042986 Presence Restrains Cervical Cancer Development via Upregulating PEG3 by Directly Targeting miR-582-3p.
    Reprod Sci. 2022 Aug 26. pii: 10.1007/s43032-022-01053.
    PubMed    
    Abstract available

  250. GERTRUDES LN, Yoneda JY, Mirandez CC, Carvalho CF, et al
    Endocervical Margins Status in Excision for Preventing Cervical Cancer According to the Transformation Zone Type.
    J Low Genit Tract Dis. 2022 Aug 26. pii: 00128360-990000000-00015.
    PubMed    
    Abstract available

  251. CHEN H, Feng R, Wang X, Cao C, et al
    Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway.
    Curr Cancer Drug Targets. 2022 Aug 22. pii: CCDT-EPUB-125779.
    PubMed    
    Abstract available

  252. SUN H, Wang D, Xu M, Gao Y, et al
    Methodological Verification-Based Screening of the Representative Ingredients for Traditional Chinese Medicine: Taking Astragalus as An Example for Interfering with Cervical Cancer.
    Curr Comput Aided Drug Des. 2022 Aug 23. pii: CAD-EPUB-125801.
    PubMed    
    Abstract available

  253. SAWAMURA T, Karashima S, Ohmori A, Sawada K, et al
    Hiccups as the first presentation of secondary adrenal insufficiency associated with advanced cervical cancer.
    Endocrinol Diabetes Metab Case Rep. 2022;2022.
    PubMed    
    Abstract available

  254. PENG Z, Liu K, Zhang Y, Hong Q, et al
    The 22-Item Benefit Finding Scale: Validation and Application among Patients with Cervical Cancer in Ethnic Minority Areas of Southwestern China.
    Contrast Media Mol Imaging. 2022;2022:8977011.
    PubMed    
    Abstract available

  255. CERQUEIRA RS, Dos Santos HLPC, Prado NMBL, Bittencourt RG, et al
    [Control of cervical cancer in the primary care setting in South American countries: systematic reviewControl del cancer cervicouterino en los servicios de atencion primaria de salud en los paises de America del Sur: revision sistematica].
    Rev Panam Salud Publica. 2022;46:e107.
    PubMed    
    Abstract available

  256. DE PREZ V, Jolidon V, Cullati S, Burton-Jeangros C, et al
    Cervical cancer (over-)screening in Europe: Balancing organised and opportunistic programmes.
    Scand J Public Health. 2022 Aug 25:14034948221118215.
    PubMed    
    Abstract available

  257. RAMON AC, Basukala O, Massimi P, Thomas M, et al
    CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer Cells.
    Viruses. 2022;14.
    PubMed    
    Abstract available

  258. DI GIUSEPPE G, Folcarelli L, Lanzano R, Napolitano F, et al
    HPV Vaccination and Cervical Cancer Screening: Assessing Awareness, Attitudes, and Adherence in Detained Women.
    Vaccines (Basel). 2022;10.
    PubMed    
    Abstract available

  259. GASIMLI K, Wilhelm L, Becker S, De Wilde RL, et al
    New Insights on the Minimal-Invasive Therapy of Cervical Cancer.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  260. LE TM, Nguyen HDT, Lee E, Lee D, et al
    Transcriptomic Immune Profiles Can Represent the Tumor Immune Microenvironment Related to the Tumor Budding Histology in Uterine Cervical Cancer.
    Genes (Basel). 2022;13.
    PubMed    
    Abstract available

  261. BEKAMPYTE J, Savukaityte A, Bartnykaite A, Ugenskiene R, et al
    TIRAP Rs8177376, Rs611953, Rs3802814, and Rs8177374 Polymorphisms and Their Association with Cervical Cancer Phenotype and Prognosis.
    Genes (Basel). 2022;13.
    PubMed    
    Abstract available

  262. LEFFERS M, Herbst J, Kropidlowski J, Prieske K, et al
    Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer Patients.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  263. CHAN WL, Cheng MH, Wu JT, Choi CW, et al
    Treatment Outcomes of Computer Tomography-Guided Brachytherapy in Cervical Cancer in Hong Kong: A Retrospective Review.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  264. CHANG CS, Min JS, Song KH, Choi CH, et al
    The Role of Conization before Radical Hysterectomy in Cervical Cancer including High Risk Factors of Recurrence: Propensity Score Matching.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  265. GARCIA-QUIROZ J, Vazquez-Almazan B, Garcia-Becerra R, Diaz L, et al
    The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics.
    Cells. 2022;11.
    PubMed    
    Abstract available

  266. MADEDDU C, Sanna E, Nemolato S, Mulas O, et al
    Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  267. CHABEREK K, Mrowiec M, Kaczmarek M, Dutsch-Wicherek M, et al
    The Creation of the Suppressive Cancer Microenvironment in Patients with HPV-Positive Cervical Cancer.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  268. ZHANG Q, Zhu H, Cui Z, Li Y, et al
    The HPV16E7 Affibody as a Novel Potential Therapeutic Agent for Treating Cervical Cancer Is Likely Internalized through Dynamin and Caveolin-1 Dependent Endocytosis.
    Biomolecules. 2022;12.
    PubMed    
    Abstract available

  269. GOMEZ-HERRANZ M, Faktor J, Yebenes Mayordomo M, Pilch M, et al
    Emergent Role of IFITM1/3 towards Splicing Factor (SRSF1) and Antigen-Presenting Molecule (HLA-B) in Cervical Cancer.
    Biomolecules. 2022;12.
    PubMed    
    Abstract available

  270. ALTUN A, Sahin Inan ZD, Yulak F
    Death receptor-dependent apoptosis and cell cycle delay induced by bioymifi in human cervical cancer cells.
    Pak J Pharm Sci. 2022;35:1031-1036.
    PubMed    
    Abstract available

  271. ZHANG J, Li X, Yang J, Zhang Y, et al
    MiR-1254 suppresses the proliferation and invasion of cervical cancer cells by modulating CD36.
    J Transl Med. 2022;19.
    PubMed    
    Abstract available

  272. FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al
    Implementation of a self-sampling HPV test for non-responders to cervical cancer screening in Japan: secondary analysis of the ACCESS trial.
    Sci Rep. 2022;12:14531.
    PubMed    
    Abstract available

  273. ZHAO YQ, Qiao YL, Lang YH
    [Challenges and opportunities to accelerate cervical cancer elimination in China].
    Zhonghua Fu Chan Ke Za Zhi. 2022;57:581-586.
    PubMed    


  274. MAKADZANGE EE, Peeters A, Joore MA, Kimman ML, et al
    The effectiveness of health education interventions on cervical cancer prevention in Africa: A systematic review.
    Prev Med. 2022 Aug 22:107219. doi: 10.1016/j.ypmed.2022.107219.
    PubMed    
    Abstract available

  275. SI C, Ou Y, Ma D, Hei L, et al
    Cytotoxic Effect of the Essential oils from Erigeron Canadensis L. on Human Cervical Cancer HeLa Cells in Vitro.
    Chem Biodivers. 2022 Aug 25:e202200436. doi: 10.1002/cbdv.202200436.
    PubMed    
    Abstract available

  276. BERNARDINI F, Ferrandina G, Ricci C, Fagotti A, et al
    Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective Study.
    Curr Oncol. 2022;29:5702-5714.
    PubMed    
    Abstract available

  277. KRAUT R, Manca D, Lofters A, Babenko O, et al
    A Case for Offering HPV Self-Sampling to Well-Screened Women. Comment on Lesack et al. Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results. Curr. Oncol. 2022, 29, 3860-3869.
    Curr Oncol. 2022;29:5368-5369.
    PubMed    
    Abstract available

  278. LI N, Ji GX, Yang ZY
    EFEMP2 increases the invasion ability of cervical cancer cells by promoting EMT via the Raf/MEK/ERK signaling pathway.
    Neoplasma. 2022 Aug 24. pii: 220117N74. doi: 10.4149/neo_2022_220117.
    PubMed    
    Abstract available

  279. CHEN H, Chen X, Zeng F, Fu A, et al
    Prognostic value of SOX9 in cervical cancer: Bioinformatics and experimental approaches.
    Front Genet. 2022;13:939328.
    PubMed    
    Abstract available

  280. MALEKZADEH E, Nourizadeh R, Farshbaf-Khalili A, Mehrabi E, et al
    The effect of decision-aid-based counseling on cervical cancer screening behavior among women: An interventional study.
    J Educ Health Promot. 2022;11:205.
    PubMed    
    Abstract available

  281. LIU Y, Hua J, Liu L, Zhang W, et al
    The value of the SUV ratio between lymph node and bone marrow in predicting pelvic lymphatic metastasis of patients with locally advanced cervical cancer: an integrated PET/CT study.
    Nucl Med Commun. 2022 Aug 25. pii: 00006231-990000000-00057.
    PubMed    
    Abstract available

  282. EGBON M, Ojo T, Aliyu A, Bagudu ZS, et al
    Challenges and lessons from a school-based human papillomavirus (HPV) vaccination program for adolescent girls in a rural Nigerian community.
    BMC Public Health. 2022;22:1611.
    PubMed    
    Abstract available

  283. SHAN X, Qian M, Wang L, Liu X, et al
    Prevalence of pelvic floor dysfunction and sexual dysfunction in cervical cancer survivors: a systematic review and meta-analysis.
    Int Urogynecol J. 2022 Aug 24. pii: 10.1007/s00192-022-05326.
    PubMed    
    Abstract available

  284. NAIDOO K, Abbai N, Tinarwo P, Sebitloane M, et al
    BV associated bacteria specifically BVAB 1 and BVAB 3 as biomarkers for HPV risk and progression of cervical neoplasia.
    Infect Dis Obstet Gynecol. 2022;2022:9562937.
    PubMed    
    Abstract available

  285. ABBAS M, Kushwaha VS, Srivastava K, Banerjee M, et al
    Understanding Role of DNA Repair and Cytochrome p-450 Gene Polymorphisms in Cervical Cancer Patient Treated With Concomitant Chemoradiation.
    Br J Biomed Sci. 2022;79:10120.
    PubMed    
    Abstract available

  286. HUANG Y, Chen L, Cai J, Yang L, et al
    Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer.
    World J Surg Oncol. 2022;20:264.
    PubMed    
    Abstract available

  287. GHANI MA, Liau J, Eskander R, Mell L, et al
    Imaging Biomarkers and Liquid Biopsy in Assessment of Cervical Cancer.
    J Comput Assist Tomogr. 2022 Aug 23. pii: 00004728-990000000-00066.
    PubMed    
    Abstract available

  288. KHUMALO PG, Carey M, Mackenzie L, Ampofo AG, et al
    Trends in cervical cancer screening research in sub-Saharan Africa: A bibliometric analysis of publications from 2001 to 2020.
    J Cancer Policy. 2022;34:100356.
    PubMed    
    Abstract available

  289. SUN W, Hang D, Han S, Fu S, et al
    Construction of circRNA-associated ceRNA network reveals the regulation of fibroblast proliferation in cervical cancer.
    Gene. 2022 Aug 19:146824. doi: 10.1016/j.gene.2022.146824.
    PubMed    
    Abstract available

  290. YANG X, Ren H, Li Z, Zhang L, et al
    A phase III randomized, controlled trial of nedaplatin versus cisplatin concurrent chemoradiotherapy in patients with cervical cancer.
    ESMO Open. 2022;7:100565.
    PubMed    
    Abstract available

  291. KOKKA F, Bryant A, Olaitan A, Brockbank E, et al
    Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Cochrane Database Syst Rev. 2022;8:CD010260.
    PubMed    
    Abstract available

  292. REZA MS, Hossen MA, Harun-Or-Roshid M, Siddika MA, et al
    Metadata analysis to explore hub of the hub-genes highlighting their functions, pathways and regulators for cervical cancer diagnosis and therapies.
    Discov Oncol. 2022;13:79.
    PubMed    
    Abstract available

  293. MOSCATO GMF, Galanti F, Criscuolo AA, Ciotti M, et al
    A retrospective study on two cohorts of immunocompetent women treated with nonavalent HPV vaccine vs. Ellagic acid complex: outcome of the evolution of persistent cervical HPV infection.
    Eur Rev Med Pharmacol Sci. 2022;26:5509-5519.
    PubMed    
    Abstract available

  294. WIERSMA D, Vinke A, Siebers AG, Melchers WJG, et al
    The added value of digital imaging to reflex cytology for triage of high-risk human papillomavirus positive self-sampled material in cervical cancer screening: A prospective cohort study.
    BJOG. 2022 Aug 3. doi: 10.1111/1471-0528.17272.
    PubMed    
    Abstract available

  295. KURMYSHKINA OV, Bogdanova AA, Kovchur PI, Fetyukov AI, et al
    RNA Sequencing and Cell Models of Virus-Associated Cancer (Review).
    Sovrem Tekhnologii Med. 2022;14:64-80.
    PubMed    
    Abstract available

  296. PENG QH, Chen K, Li JY, Chen L, et al
    Analysis of Treatment Outcomes and Prognosis After Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer.
    Front Oncol. 2022;12:926840.
    PubMed    
    Abstract available

  297. GUO C, Dai W, Zhou Q, Gui L, et al
    Cervicovaginal microbiota significantly changed for HPV-positive women with high-grade squamous intraepithelial lesion.
    Front Cell Infect Microbiol. 2022;12:973875.
    PubMed    
    Abstract available

  298. LU A, Lu G
    Application of MRI and CT Images in Surgical Treatment of Early Cervical Cancer.
    Scanning. 2022;2022:1592449.
    PubMed    
    Abstract available

  299. JIANG L, Li D, Wang C, Liao J, et al
    Decreased Expression of Karyopherin-alpha 1 is Related to the Malignant Degree of Cervical Cancer and is Critical for the Proliferation of Hela Cells.
    Pathol Oncol Res. 2022;28:1610518.
    PubMed    
    Abstract available

  300. OJHA PS, Maste MM, Tubachi S, Patil VS, et al
    Human papillomavirus and cervical cancer: an insight highlighting pathogenesis and targeting strategies.
    Virusdisease. 2022;33:132-154.
    PubMed    
    Abstract available

  301. BREWER N, Foliaki S, Gray M, Potter JD, et al
    Pasifika women's knowledge and perceptions of cervical-cancer screening and the implementation of self-testing in Aotearoa New Zealand: A qualitative study.
    Lancet Reg Health West Pac. 2022;28:100551.
    PubMed    
    Abstract available

  302. LI H, Li L, Sun J, Dong S, et al
    Value of TCT combined with serum CA153 and CA50 in early diagnosis of cervical cancer and precancerous lesions.
    Pak J Med Sci. 2022;38:1471-1476.
    PubMed    
    Abstract available

  303. BOLORMAA E, Choe SA, Son M, Ki M, et al
    Income-based disparity in the risk distant-stage cervical cancer and mortality after introduction of a national cancer screening program.
    Epidemiol Health. 2022 Aug 11:e2022066. doi: 10.4178/epih.e2022066.
    PubMed    
    Abstract available

  304. ELSHAMI M, Abukmail H, Al-Slaibi I, Alser M, et al
    Awareness of human papillomavirus and acceptability of the vaccine among women in Palestine: is it time for policy adjustment?
    BMC Womens Health. 2022;22:352.
    PubMed    
    Abstract available

  305. AARTHY M, Muthuramalingam P, Ramesh M, Singh SK, et al
    Unraveling the multi-targeted curative potential of bioactive molecules against cervical cancer through integrated omics and systems pharmacology approach.
    Sci Rep. 2022;12:14245.
    PubMed    
    Abstract available

  306. ZHANG A, Hu Q, Song J, Dai Y, et al
    Value of non-Gaussian diffusion imaging with a fractional order calculus model combined with conventional MRI for differentiating histological types of cervical cancer.
    Magn Reson Imaging. 2022 Aug 18. pii: S0730-725X(22)00148.
    PubMed    
    Abstract available

  307. LIANG M, Liu S, Huang W, Jiang L, et al
    Analysis of Mechanism of Action of Cuprous Oxide Nanoparticles in Treatment of Cervical Cancer under Real-time Ultrasound Elastography.
    Cell Mol Biol (Noisy-le-grand). 2022;68:402-410.
    PubMed    
    Abstract available

  308. DU QY, Huo FC, Du WQ, Sun XL, et al
    METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.
    Oncogene. 2022 Aug 20. pii: 10.1038/s41388-022-02435.
    PubMed    
    Abstract available

  309. POWER R, Ussher JM, Hawkey A, Missiakos O, et al
    Co-designed, culturally tailored cervical screening education with migrant and refugee women in Australia: a feasibility study.
    BMC Womens Health. 2022;22:353.
    PubMed    
    Abstract available

  310. RAJKUMAR D, Veeraiah S, Sudhakar R, Ganeshrajah S, et al
    Perceived psychosexual dimensions of cervical cancer survivors in India-An exploratory study.
    Psychooncology. 2022 Aug 20. doi: 10.1002/pon.6021.
    PubMed    
    Abstract available

  311. RAPITI E, Fournier E, Schaffar R
    High burden of invasive and non-invasive cancer among women aged 20-49 years: the situation in Geneva, Switzerland.
    BMC Womens Health. 2022;22:349.
    PubMed    
    Abstract available

  312. VATS A, Trejo-Cerro O, Massimi P, Banks L, et al
    Regulation of HPV E7 Stability by E6-Associated Protein (E6AP).
    J Virol. 2022 Aug 2:e0066322. doi: 10.1128/jvi.00663.
    PubMed    
    Abstract available

  313. RATNASAMY P, Chagpar AB
    HPV vaccination and factors influencing vaccine uptake among people of Indian ancestry living in the United States.
    Epidemiol Infect. 2022;150:e152.
    PubMed    
    Abstract available

  314. CORONADO MARTIN PJ, Gonzalez Gonzalez V, Fasero Laiz M
    Value of colposcopy with dynamic spectral imaging in the detection and evolution of high-grade cervical lesions.
    Expert Rev Med Devices. 2022;19:525-532.
    PubMed    
    Abstract available

  315. BENSON R, Rodgers J, Nelder C, Clough A, et al
    The impact of an educational tool in cervix image registration across three imaging modalities.
    Br J Radiol. 2022 May 26:20211402. doi: 10.1259/bjr.20211402.
    PubMed    
    Abstract available

  316. SABATINO SA, Thompson TD, White MC, Shapiro JA, et al
    Cancer Screening Test Use-U.S., 2019.
    Am J Prev Med. 2022;63:431-439.
    PubMed    
    Abstract available

  317. LI C, Li X, Zhang Y, Wu L, et al
    DSCAM-AS1 promotes cervical carcinoma cell proliferation and invasion via sponging miR-338-3p.
    Environ Sci Pollut Res Int. 2022;29:58906-58914.
    PubMed    
    Abstract available

  318. HECHT ML, BeLue R, Ray A, Hopfer S, et al
    HPV Vaccine Intent among Adult Women Receiving Care at Community Health Centers.
    J Cancer Educ. 2022;37:1186-1193.
    PubMed    
    Abstract available

  319. PENG H, He X, Wang Q
    Immune checkpoint blockades in gynecological cancers: A review of clinical trials.
    Acta Obstet Gynecol Scand. 2022 Jun 25. doi: 10.1111/aogs.14412.
    PubMed    
    Abstract available

  320. AASBO G, Trope A, Nygard M, Christiansen IK, et al
    HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial.
    Br J Cancer. 2022 Aug 23. pii: 10.1038/s41416-022-01954.
    PubMed    
    Abstract available

  321. MCDANIELS-DAVIDSON C, Feng CH, Martinez ME, Canchola AJ, et al
    Improved survival in cervical cancer patients receiving care at National Cancer Institute-designated cancer centers.
    Cancer. 2022 Aug 2. doi: 10.1002/cncr.34404.
    PubMed    
    Abstract available

  322. MILLER KM, Friedman CF
    Bifunctional Blockade: A Novel Immunotherapy Approach for Cervical Cancer.
    Clin Cancer Res. 2022 Aug 10. pii: 707611. doi: 10.1158/1078-0432.CCR-22-1779.
    PubMed    
    Abstract available

  323. OKODO M, Okayama K, Misawa Y, Tsukakoshi N, et al
    Effects of the menstrual cycle on cytological false-negatives in women with persistent cervical intraepithelial neoplasia.
    Cytopathology. 2022;33:591-599.
    PubMed    
    Abstract available

  324. COSTA AF, Pogere A, Pasinato APBF, Onofre ASC, et al
    DNA image cytometry parameters to identify high-grade cervical lesions.
    Cytopathology. 2022;33:563-571.
    PubMed    
    Abstract available

  325. ZHANG L, Qi R, Wang L, Jiang F, et al
    Clinical value of the ThinPrep cytologic test with E6/E7 mRNA detection for cervical cancer screening in disease diagnosis.
    Diagn Cytopathol. 2022 Aug 1. doi: 10.1002/dc.25025.
    PubMed    
    Abstract available

  326. CHO S, Lee SM, Lee S, Cho HW, et al
    The necessity of continuing cervical cancer screening of elderly Korean women aged 65 years or older.
    Diagn Cytopathol. 2022 Jul 30. doi: 10.1002/dc.25021.
    PubMed    
    Abstract available

  327. OAKNIN A, Monk BJ, Vergote I, Cristina de Melo A, et al
    EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer.
    Eur J Cancer. 2022 Jul 31. pii: S0959-8049(22)00160.
    PubMed    
    Abstract available

  328. LEITAO MM JR, Zhou QC, Brandt B, Iasonos A, et al
    The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes.
    Gynecol Oncol. 2022 Jul 22. pii: S0090-8258(22)00434.
    PubMed    
    Abstract available

  329. LI H, Wang S, Liu Y, Wang T, et al
    Prophylactic extended-field irradiation for locally advanced cervical cancer.
    Gynecol Oncol. 2022 Jul 19. pii: S0090-8258(22)00481.
    PubMed    
    Abstract available

  330. SY F, Greuel M, Winkler V, Bussmann H, et al
    Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: A systematic review and meta-analysis.
    Gynecol Oncol. 2022 Jun 30. pii: S0090-8258(22)00416.
    PubMed    
    Abstract available

  331. SIVARS L, Hellman K, Crona Guterstam Y, Holzhauser S, et al
    Circulating cell-free tumor human papillomavirus DNA is a promising biomarker in cervical cancer.
    Gynecol Oncol. 2022 Jul 30. pii: S0090-8258(22)00512.
    PubMed    
    Abstract available

  332. ALHOLM Z, He D, Ting J, Zhang YJ, et al
    Real-world treatment drop-off among recurrent or metastatic cervical cancer patients: A US community oncology-based analysis.
    Gynecol Oncol. 2022 Jul 29. pii: S0090-8258(22)00509.
    PubMed    
    Abstract available

  333. BOGANI G, Donato VD, Scambia G, Landoni F, et al
    Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer.
    Gynecol Oncol. 2022 Jul 28. pii: S0090-8258(22)00494.
    PubMed    
    Abstract available

  334. KIM Y, Kim SI, Kim H, Lee M, et al
    Open versus minimally invasive radical hysterectomy for early cervical cancer: A two-center retrospective cohort study with pathologic review of usual-type adenocarcinoma and adenosquamous carcinoma.
    Gynecol Oncol. 2022 Aug 12. pii: S0090-8258(22)00541.
    PubMed    
    Abstract available

  335. ADEBAMOWO SN, Befano B, Cheung LC, Rodriguez AC, et al
    Different human papillomavirus types share early natural history transitions in immunocompetent women.
    Int J Cancer. 2022;151:920-929.
    PubMed    
    Abstract available

  336. ZHANG L, Zhao X, Hu S, Chen S, et al
    Triage performance and predictive value of the human gene methylation panel among women positive on self-collected HPV test: results from a prospective cohort study.
    Int J Cancer. 2022 Apr 22. doi: 10.1002/ijc.34041.
    PubMed    
    Abstract available

  337. JOSHI S, Muwonge R, Kulkarni V, Mandolkar M, et al
    Can we increase the cervical cancer screening interval with an HPV test for women living with HIV? Results of a cohort study from Maharashtra, India.
    Int J Cancer. 2022 Jul 19. doi: 10.1002/ijc.34221.
    PubMed    
    Abstract available

  338. DESAI KT, Adepiti CA, Schiffman M, Egemen D, et al
    Redesign of a rapid, low-cost HPV typing assay to support risk-based cervical screening and management.
    Int J Cancer. 2022 Jun 6. doi: 10.1002/ijc.34151.
    PubMed    
    Abstract available

  339. GIORGI ROSSI P, Ronco G, Mancuso P, Carozzi F, et al
    Performance of HPV E6/E7 mRNA Assay as Primary Screening Test. Results from the NTCC2 Trial.
    Int J Cancer. 2022 May 17. doi: 10.1002/ijc.34120.
    PubMed    
    Abstract available

  340. SAUVAGET C, Bazikamwe S, Lucas E, Ndayikengurukiye A, et al
    Evaluation of effectiveness, acceptability and safety of thermal ablation in the treatment of cervical neoplasia in Burundi.
    Int J Cancer. 2022;151:1120-1126.
    PubMed    
    Abstract available

  341. ADCOCK R, Nedjai B, Lorincz A, Scibior-Bentkowska D, et al
    DNA methylation testing with S5 for triage of high-risk HPV positive women.
    Int J Cancer. 2022 Apr 27. doi: 10.1002/ijc.34050.
    PubMed    
    Abstract available

  342. HU SY, Zhao XL, Zhao FH, Wei LH, et al
    Implementation of Visual Inspection with Acetic Acid and Lugol's Iodine for Cervical Cancer Screening in Rural China.
    Int J Gynaecol Obstet. 2022 Jul 24. doi: 10.1002/ijgo.14368.
    PubMed    
    Abstract available

  343. DAU H, Trawin J, Nakisige C, Payne BA, et al
    The social and economic impacts of cervical cancer on women and children in low- and middle-income countries: a systematic review.
    Int J Gynaecol Obstet. 2022 Aug 13. doi: 10.1002/ijgo.14395.
    PubMed    
    Abstract available

  344. RAMIREZ M, de la Fuente J, Andia D, Hernandez JJ, et al
    "HPV vaccination coverage in women between 15-55 years in Spain. Temporal trend during the period 2007-2020".
    Int J Gynaecol Obstet. 2021 Dec 14. doi: 10.1002/ijgo.14067.
    PubMed    


  345. FRANCOEUR AA, Liao CI, Casear MA, Chan A, et al
    The increasing incidence of stage IV cervical cancer in the USA: what factors are related?
    Int J Gynecol Cancer. 2022 Aug 18. pii: ijgc-2022-003728.
    PubMed    
    Abstract available

  346. NOBREGA L, Zanon JR, Andrade CEEMDC, Schmidt RL, et al
    Prognostic role of hydronephrosis in the treatment of patients with locally advanced cervical cancer: a retrospective cohort.
    Int J Gynecol Cancer. 2022 Aug 16. pii: ijgc-2022-003679.
    PubMed    
    Abstract available

  347. GLICKMAN A, Diaz-Feijoo B, Agusti N, Carreras-Dieguez N, et al
    Laparoscopically assisted radical vaginal hysterectomy in early-stage cervical cancer.
    Int J Gynecol Cancer. 2022 Aug 22. pii: ijgc-2022-003670.
    PubMed    


  348. MARAR M, Simiele E, Niedermayr T, Kidd EA, et al
    Applying 3D-Printed Templates in High-Dose-Rate Brachytherapy for Cervix Cancer: Simplified Needle Insertion for Optimized Dosimetry.
    Int J Radiat Oncol Biol Phys. 2022;114:111-119.
    PubMed    
    Abstract available

  349. LIAO H, Pan Y, Pan Y, Shen J, et al
    [Retracted] MicroRNA874 is downregulated in cervical cancer and inhibits cancer progression by directly targeting ETS1.
    Oncol Rep. 2022;48.
    PubMed    
    Abstract available

  350. LIU C, Feng H, Song L, Li S, et al
    Synergistic effects of thalidomide and cisplatin are mediated via the PI3K/AKT and JAK1/STAT3 signaling pathways in cervical cancer.
    Oncol Rep. 2022;48.
    PubMed    
    Abstract available

  351. MARTINEZ A, Chantalat E, Angeles MA, Ferron G, et al
    Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer.
    BMC Cancer. 2022;22:810.
    PubMed    
    Abstract available

  352. LI M, Xiao Y, Liu M, Ning Q, et al
    MiR-26a-5p regulates proliferation, apoptosis, migration and invasion via inhibiting hydroxysteroid dehydrogenase like-2 in cervical cancer cell.
    BMC Cancer. 2022;22:876.
    PubMed    
    Abstract available

  353. NASCIMENTO NPG, Gally TB, Borges GF, Campos LCG, et al
    Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis.
    BMC Cancer. 2022;22:862.
    PubMed    
    Abstract available

  354. TIITI TA, Selabe SG, Bogers J, Lebelo RL, et al
    High prevalence of and factors associated with human papillomavirus infection among women attending a tertiary hospital in Gauteng Province, South Africa.
    BMC Cancer. 2022;22:854.
    PubMed    
    Abstract available

  355. GLASMEYER L, Mcharo RD, Torres L, Lennemann T, et al
    Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting.
    BMC Cancer. 2022;22:892.
    PubMed    
    Abstract available

  356. GEBRIE A
    Disease progression role as well as the diagnostic and prognostic value of microRNA-21 in patients with cervical cancer: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0268480.
    PubMed    
    Abstract available

  357. LIU SS, Chan KKL, Wei TN, Tse KY, et al
    Clinical performance of the Roche Cobas 4800 HPV test for primary cervical cancer screening in a Chinese population.
    PLoS One. 2022;17:e0272721.
    PubMed    
    Abstract available

  358. FRIEBEL-KLINGNER TM, Iyer HS, Ramogola-Masire D, Bazzett-Matabele L, et al
    Evaluating the geographic distribution of cervical cancer patients presenting to a multidisciplinary gynecologic oncology clinic in Gaborone, Botswana.
    PLoS One. 2022;17:e0271679.
    PubMed    
    Abstract available

  359. CORREA RM, Baena A, Valls J, Colucci MC, et al
    Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America.
    PLoS One. 2022;17:e0272205.
    PubMed    
    Abstract available

  360. YANG Z, Zhang Y, Stubbe-Espejel A, Zhao Y, et al
    Vaginal microbiota and personal risk factors associated with HPV status conversion-A new approach to reduce the risk of cervical cancer?
    PLoS One. 2022;17:e0270521.
    PubMed    
    Abstract available

  361. JO A, Joh HM, Bae JH, Kim SJ, et al
    Plasma activated medium prepared by a bipolar microsecond-pulsed atmospheric pressure plasma jet array induces mitochondria-mediated apoptosis in human cervical cancer cells.
    PLoS One. 2022;17:e0272805.
    PubMed    
    Abstract available

  362. ROMLI R, Abd Rahman R, Chew KT, Mohd Hashim S, et al
    Empirical investigation of e-health intervention in cervical cancer screening: A systematic literature review.
    PLoS One. 2022;17:e0273375.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;